Randomized Controlled Crossover Trial of Ketamine in Obsessive-Compulsive Disorder: Proof-of-Concept
Neuropsychopharmacology, 2013 (Rodriguez et al.)
A randomized, placebo-controlled crossover trial finding that a single IV ketamine infusion produced a significantly higher response rate than placebo in patients with treatment-resistant OCD. One of the first controlled trials in this area.
View on PubMed →
